StemCyte, Inc.
6Patents
5Active
6Granted
45Portfolio score
Filing activity: Dec 20, 2000 → Apr 23, 2018 · 3 expiring within 5 years
Most-cited patents
| Patent | Title | Area | Cited by | Status |
|---|---|---|---|---|
| US6670124B1 | High throughput methods of HLA typing | Chemistry; Metallurgy | 37 | Expired |
| US8048619B2 | Method of treating a hematopoietic associated disease or disorder with plasma-depleted, but not erythrocyte-depleted cord blood compositions | Chemistry; Metallurgy | 12 | Active |
| US8062837B2 | Plasma-depleted, not erythrocyte-depleted, cord blood compositions and method of making | Emerging Cross-Sectional Technologies | 1 | Active |
| US10400212B2 | Stem cell packaging and shipping | Mechanical Engineering; Lighting; Heating | 0 | Active |
| US9951309B2 | Stem cell packaging and shipping | Mechanical Engineering; Lighting; Heating | 0 | Active |
| US11318170B2 | Treatment of brain damage using umbilical cord blood cells | Human Necessities | 0 | Active |
Source: USPTO / EPO open patent data. Counts and citation impact are objective bibliographic measures.